Substance specific to human PD-1

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9783609
APP PUB NO 20150118234A1
SERIAL NO

14584664

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a substance specific to human PD-1 comprising a part that recognizes human PD-1, a part that recognizes a membrane protein in cell membrane of human PD-1-expressing cells, and linkers. Since the substance specific to human PD-1 selectively can recognize human PD-1 and a membrane protein on cell membrane of human PD-1-expressing cells and can transmit inhibitory signal of human PD-1, it is useful for therapy and/or prevention of diseases caused by immunopathy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONO PHARMACEUTICAL CO LTD1-5 DOSHO-MACHI 2-CHOME CHUO-KU OSAKA-SHI OSAKA 541-8526

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Honjo, Tasuku Kyoto, JP 57 3296
Matsuo, Masayoshi Osaka, JP 12 681
Miyamoto, Masakazu Osaka, JP 14 487
Shibayama, Shiro Osaka, JP 84 3261
Takeda, Kazuhiko Osaka, JP 19 489
Yoshida, Takao Osaka, JP 115 1826

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 10, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 10, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00